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Summary
 
The E2A proteins, E12 and E47, are required for progression through multiple developmental
pathways, including early B and T lymphopoiesis. Here, we provide in vitro and in vivo evi-
dence demonstrating that E47 activity regulates double-positive thymocyte maturation. In the
absence of E47 activity, positive selection of both major histocompatibility complex (MHC)
class I– and class II–restricted T cell receptors (TCRs) is perturbed. Additionally, development
of CD8 lineage T cells in an MHC class I–restricted TCR transgenic background is sensitive to
the dosage of E47. Mice deficient for E47 display an increase in production of mature CD4 and
CD8 lineage T cells. Furthermore, ectopic expression of an E2A inhibitor helix-loop-helix pro-
tein, Id3, promotes the in vitro differentiation of an immature T cell line. These results demon-
strate that E2A functions as a regulator of thymocyte positive selection.
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D
 
uring maturation in the thymus, T lineage cells inter-
act with peptide containing MHC proteins either to
differentiate or, alternatively, to undergo programmed cell
death. Immature double-positive (DP)
 
1
 
 thymocytes that ex-
press TCRs possessing high affinity for self-peptide–MHC
complexes undergo apoptosis, a process referred to as nega-
tive selection. Those cells that express TCRs with sufficient
affinity for self-peptide–MHC complexes are induced to dif-
ferentiate into mature single-positive (SP) T cells through a
process termed positive selection. Any DP thymocyte ex-
pressing a TCR that is incapable of binding self-peptide–
MHC complexes or binding with too low an affinity dies
“by neglect” (1–3).
A large number of receptor-mediated signaling pathways
and downstream effector molecules that promote positive
versus negative selection have been described. However,
the nuclear targets of those signaling events remain largely
unknown. Previous studies have shown that the helix-
loop-helix (HLH) proteins, E12 and E47, are required dur-
ing the early stages of T lineage development (4).
 
 
 
E12 and
E47 are encoded by one gene, designated E2A, and arise
through alternative splicing of the exon encoding the HLH
domain (5, 6). E12 and E47 bind to sequence motifs, termed
E-boxes, that are found in the regulatory regions of numer-
ous lineage-specific genes (5, 6). In B lymphocytes, E47 ho-
modimeric complexes are the predominate E-box binding
species. However, in thymocytes, a portion of the E47 pro-
tein binds DNA as a complex with HeLa E-box binding
protein (HEB), another HLH protein which is expressed at
particularly high levels in developing T cells (7).
Several putative B and T lineage–specific E2A target genes
have been described. For example, overexpression of either
E12 or E47 in pre-T, macrophage, or pro-B cell lines leads
to the induction of the B cell–specific genes 
 
l
 
5, V–pre-B,
early B cell factor (EBF), and Pax-5 (8–10). Additionally,
recombination activating gene (RAG)-1 expression is in-
duced upon ectopic expression of either E12 or E47 in a
pre-T or macrophage cell line (9, 10). Another study using
enforced expression of Id3, a dominant negative inhibitor
of E2A activity, in committed T cell progenitors has also
suggested that E2A and/or HEB regulates RAG gene ex-
pression (11).
Specific functions of the E2A proteins have been most
extensively studied in the context of B lineage develop-
ment, which is completely blocked at a stage preceding the
onset of immunoglobulin gene rearrangement in E2A-defi-
cient mice (4, 12). However, recent experiments have dem-
onstrated that E2A activity is also critical for proper T lineage
development. Specifically, E2A-deficient mice are lacking
in certain populations of 
 
g
 
/
 
d
 
 T cells. This deficiency in
distinct 
 
g
 
/
 
d
 
 T cell populations is due, in part, to perturba-
tions in TCR-
 
g
 
/
 
d
 
 V(D)J recombination (13). Within the 
 
a
 
/
 
b
 
T cell lineage, development is partially blocked at the dou-
ble-negative stage, before the initiation of TCR 
 
b
 
 chain
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2M, 
 
b
 
2-microglobulin; BrdU, bromode-
oxyuridine; DP, double-positive; EGFP, enhanced green fluorescent pro-
tein; HEB, HeLa E-box binding protein; HLH, helix-loop-helix; HSA,
heat stable antigen; PDP, peripheral DP; RAG, recombination activating
gene; SP, single-positive; WCE, whole cell extract. 
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gene rearrangement. This early developmental defect likely
contributes to the significant decrease in total thymocyte
numbers observed in E2A-deficient mice (7). In other stud-
ies, overexpression of the negative regulator, Id3, in pro-
genitor thymocytes completely blocked T lineage develop-
ment (14). We have shown previously that E2A-deficient
thymi show increased percentages of mature SP T cells and
decreased proportions of immature DP cells (7). These data
raised the possibility that the E2A proteins are functionally
important beyond the double-negative stage of thymocyte
development. Here, we reveal a role for E2A in DP thy-
mocyte maturation. In the absence of E47 activity, an in-
creased proportion of DP thymocytes matures into CD4
and CD8 SP thymocytes. Interestingly, maturation of CD8
SP thymocytes in class I–restricted TCR transgenic mice is
sensitive to the dosage of E47, whereas CD4
 
1
 
 thymocyte
maturation in class II–restricted TCR transgenic mice is
not. In addition, inhibition of E47 DNA binding activity in
a DP T cell line by retroviral transduction of a dominant
negative inhibitor promotes the maturation of these cells.
Taken together, these data suggest that E47 activity con-
tributes to the regulation of thymocyte positive selection.
 
Materials and Methods
 
Mouse Strains.
 
The E2A- and E47-deficient mice have been
described previously (4, 15). The 
 
b
 
2-microglobulin (
 
b
 
2M) mice
were purchased from The Jackson Laboratory. All mice were an-
alyzed between 4 and 7 wk of age.
 
In Vitro Viability Analysis.
 
Total thymocytes from E47- or E2A-
deficient mice and wild-type littermates were dissected into
RPMI medium containing 10% fetal bovine serum and 50 
 
m
 
M
2-ME and supplemented with glutamine, penicillin, and strepto-
mycin. The cells were stained with antibodies to CD4 and CD8
or with propidium iodide (to determine viability) before culture
(time 
 
5 
 
0). The cells were then placed in culture at 37
 
8
 
C plus 5%
CO
 
2
 
 for 28 h before harvesting and staining with anti-CD4–PE
and anti-CD8–FITC antibodies and propidium iodide to deter-
mine cell viability. The percentage of viable DP cells was deter-
mined by multiplying the number of viable cells at 28 h by the
percentage of DP cells at 28 h and dividing this by the number of
DP cells put into culture at time 
 
5 
 
0.
 
Flow Cytometric Analysis.
 
Staining of the cells has been de-
scribed previously (4). For two-color analysis, cells were stained
with anti-CD4–PE (RM4-5; PharMingen), anti-CD8
 
a
 
–FITC
(53-6.7; PharMingen), anti–TCR-
 
a
 
/
 
b
 
–FITC (H57-597; Phar-
Mingen), and anti-CD69–PE (H1.2F3; PharMingen). Hybridoma
supernatant from the T3.70 line, provided by Dr. Ellen Robey
(University of California, Berkeley, CA), was used for the V
 
a
 
3
staining. For three-color analysis, cells were stained with anti-CD4–
TriColor (CT-CD4; Caltag), anti-CD8
 
a
 
–PE (53-6.7; PharMin-
gen), anti-CD69–FITC (H1.2F3), anti–heat stable antigen (HSA)–
FITC (M1/69; PharMingen), and anti–TCR-
 
a
 
/
 
b
 
–FITC. Cells
were analyzed on a FACScan™ (Becton Dickinson), and live
cells were gated on the basis of forward and side scatter.
 
Bromodeoxyuridine Analysis of Thymocyte Development.
 
For the
kinetic analysis of thymic development, mice were continuously
exposed to the thymidine analogue bromodeoxyuridine (BrdU;
0.8 mg/ml) in their drinking water for the indicated times. Thymo-
cytes were labeled with antibodies extracellularly as described above
 
using biotinylated anti-CD4 or anti–TCR-
 
a
 
/
 
b
 
 (PharMingen) and
PE-labeled anti-CD8 or anti-CD69 (PharMingen). Cells were
then fixed and stained with FITC-labeled anti-BrdU (Becton
Dickinson) as described previously (16).
 
Retroviral Supernatant Production and T Lymphoma Transduction.
 
The 16610D9 cell line was derived from a thymoma that devel-
oped spontaneously in a p53-deficient mouse and was adapted to
culture. The cells were subcloned to generate the 16610D9 line,
which was then cultured at 37
 
8
 
C plus 5% CO
 
2
 
 in Optimem
(GIBCO BRL) containing 10% fetal bovine serum and 50 
 
m
 
M
2-ME and supplemented with glutamine, penicillin, and streptomy-
cin. The retroviral vector LZRSpBMN-linker-IRES-EGFP (S-003)
was obtained from Hergen Spits (The Netherlands Cancer Institute,
Amsterdam, The Netherlands). The mouse Id3 cDNA that was
cloned into the polylinker was generated by PCR of an Id3 cDNA
with the following primers: Id3 forward, 5
 
9
 
-CCGGAATTCA-
TGGACTACAAGGACGACGATGACAAGGGATCCATGAA-
GGCGCTGAGCCCGGTG; and Id3 reverse, 5
 
9
 
-CCGGAAT-
TCTCAGTGGCAAAAGCTCCTC, to generate FLAG-tagged
Id3. The PCR product was cloned into pBSK, digested out of pBSK
with EcoRI, and cloned into the EcoRI site in S-003. The 
 
f
 
NX-
eco packaging line (17) was transfected with the retroviral con-
structs by calcium phosphate precipitation. The transfected cells
were switched to 16610D9 culture medium 24 h after transfec-
tion, and supernatants were harvested after an additional 24 h.
Transduction of the 16610D9 cells was performed as described
previously (18). Cells were harvested 48 h after infection and an-
alyzed by flow cytometry as described above using PE-conju-
gated antibodies (with the exception of CD4, which was TriColor
conjugated), or lysed to make whole cell extracts (WCEs). To
prepare WCE, cells were pelleted, washed once in cold 1
 
3
 
 PBS,
and the cell pellet was then frozen on dry ice for 
 
z
 
15 min. The
pellet was thawed, resuspended in 15 
 
m
 
l/10
 
6
 
 cells cold buffer C
(20 mM Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol, 1 mM PMSF plus protease inhibitors)
containing 1% NP-40, and vortexed vigorously for 2 min at 4
 
8
 
C.
Debris was pelleted by spinning at high speed in a microfuge at
4
 
8
 
C, and the supernatant was removed as the WCE. Protein con-
centrations were determined using Bio-Rad’s protein assay reagent
as described by the manufacturer. Double-stranded DNA probes
were end-labeled using T4 polynucleotide kinase and purified over
a G25 Sepharose column. 15 
 
m
 
g of WCE was used in a gel shift as-
say as described previously (19). The sequence of the 
 
m
 
E5 oligo
probe is as follows: 5
 
9
 
-TCGAAGAACACCTGCAGCAGCT-3
 
9
 
.
 
Results
 
Absence of E2A Leads to Altered Thymocyte Maturation.
 
Previous studies have established that mutant mice lacking
both E12 and E47 exhibit abnormalities in thymocyte de-
velopment (7). To generate sufficient numbers of mice to
further characterize the T cell phenotype, we analyzed
E47-deficient mice, which have a significantly lower rate
of postnatal lethality compared with the E2A
 
2
 
/
 
2
 
 mice (15).
However, we note that the E47-deficient mice also express
reduced levels of the E12 protein compared with control
littermates (15). We analyzed thymocytes derived from
4–6-wk-old E2A- or E47-deficient mice for the expression
of CD4 and CD8 by flow cytometry. Wild-type and E47 or
E2A heterozygous mice had virtually identical thymic profiles
(data not shown). However, E2A- and E47-deficient thymi 
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showed significant decreases in the percentage of DP thymo-
cytes compared with their heterozygous littermates (Fig. 1 A).
In contrast, the proportions of both the CD4 and CD8 SP
populations were increased an average of two- to threefold
in the E2A- and E47-deficient thymi (Fig. 1, A and B).
Within the thymus, an increase in the relative percentage
of mature SP thymocytes can arise through several mecha-
nisms. For example, either aberrant proliferation of the SP
populations, increased frequency of apoptosis within the DP
population, or increased maturation of the DP cells could ex-
plain the phenotypical changes observed in the E2A- and
E47-deficient mice. To begin to address these possibilities,
we analyzed thymi from E2A-deficient mice for incorpora-
tion of BrdU and survival in vitro. E2A-deficient mice and
control littermates were injected with BrdU, and the thy-
mic subpopulations were analyzed for BrdU incorporation
24 h after injection. We found no increase in the percent-
age of SP thymocytes from E2A-deficient mice staining
positive for BrdU compared with the control littermates
(data not shown). Thus, the increased percentage of SP cells
is not a result of abnormal proliferation within this popula-
tion. To determine whether the absence of E2A promotes
DP cell death, we isolated total thymocytes from E47- or
E2A-deficient mice and wild-type littermates and analyzed
the viability of the cells after 28 h in culture. Whereas an
average of 52% of the wild-type DP cells was alive after the
culture period, only 
 
z
 
17% of the E47- and E2A-deficient
DP cells survived (Table I, and data not shown). Similar per-
centages of wild-type or E2A-deficient CD4
 
1
 
 cells were alive
after 28 h in culture, suggesting that the increase in cell death
is specific to the DP population (Table I). Thus, DP thymo-
cytes lacking E2A activity display decreased survival in vitro.
To address the possibility of an increase in DP thymo-
cyte maturation, we further characterized the changes in the
T cell populations by analyzing thymocytes from E2A- and
E47-deficient mice for the expression of TCR-
 
a
 
/
 
b
 
 and
CD69. During normal thymocyte development, expression
of both TCR-
 
a
 
/
 
b
 
 and CD69 increases upon positive se-
lection (20–24). However, whereas SP thymocytes retain
high levels of TCR-
 
a
 
/
 
b
 
 expression, CD69 levels are sub-
sequently downregulated upon completion of maturation
(21, 24, 25). Thus, TCR
 
hi
 
CD69
 
1
 
 cells represent those thy-
mocytes in the process of positive selection, whereas TCR
 
hi
 
CD69
 
2
 
 thymocytes have completed the maturation pro-
cess. We find that thymocytes derived from E2A- or E47-
deficient mice have a three- to fourfold increase in the
proportion of TCR
 
hi
 
CD69
 
2
 
 cells compared with their lit-
termates (Fig. 2, and data not shown). The absolute number
of mature TCR
 
hi
 
CD69
 
2
 
 thymocytes is increased an aver-
age of 1.5–3-fold (data not shown). These data indicate that
the absence of E47 leads to an increase in the proportion of
SP cells that have completed thymocyte maturation, and
suggest that E47 might have an additional role in regulating
DP thymocyte differentiation.
 
Positive Selection in E47-deficient Mice Expressing Class I–
and Class II–restricted TCR Transgenes.
 
To further explore
Figure 1. Increased percentage of SP thymocytes in E2A- and E47-
deficient mice. (A) Two-color flow cytometric analysis of thymocytes from
4–6-wk-old E2A- and E47-deficient mice and heterozygous littermates.
Thymocytes were analyzed by staining with anti-CD8a and anti-CD4.
The numbers in each quadrant indicate the percentage of thymocytes in
that population. (B) The percentage of mature CD41 (left) or CD81 (right)
thymocytes is plotted for eight to nine individual E2A- and E47-deficient
mice and heterozygous controls. The horizontal bars indicate the average
percentage of CD41 or CD81 thymocytes for each genotype.
 
Table I.
 
In Vitro Viability of DP and CD4
 
1
 
 Thymocytes from 
E2A-deficient Mice and Wild-type Littermates
 
Percent DP Percent CD4
 
1
 
Exp.
 
1
 
/
 
12
 
/
 
21
 
/
 
12
 
/
 
2
 
14 41 57 4 7 9
25 61 48 5 8 2
35 52 39 21 0 0
Ave. 52 (
 
6
 
 6) 17 (
 
6
 
 5) 84 (
 
6
 
 9) 87 (
 
6
 
 11)
Total thymocytes from E2A-deficient mice or wild-type littermates
were stained with antibodies against the CD4 and CD8 coreceptors and
with propidium iodide before culture and after 28 h in culture. The
percentage of viable DP or CD4
 
1
 
 cells for three independent
experiments is shown. The average (Ave.) for the three experiments
(Exp.) is indicated, with the SD in parentheses. 
1608
 
E2A Activity Regulates Thymocyte Selection
 
whether the absence of E47 leads to an increase in thy-
mocyte maturation, E47-deficient mice were crossed to
AND TCR mice which express a class II–restricted TCR
transgene. Maturation of CD4 SP thymocytes is strongly
enhanced in H-2
 
b
 
 mice expressing the AND TCR (26).
Thymocytes derived from E47-deficient mice and wild-
type or heterozygous littermates carrying the AND trans-
gene were analyzed by flow cytometry for the expression
of CD4 and CD8. As expected, E47
 
1
 
/
 
1
 
;AND mice con-
tained a high fraction of mature CD4
 
1
 
 cells and a corre-
spondingly lower fraction of immature DP thymocytes
than nontransgenic thymi (Fig. 3, top panels). Thymic pro-
files from E47
 
1
 
/
 
2
 
;AND mice were not significantly differ-
ent from the E47
 
1
 
/
 
1
 
;AND profiles (Fig. 3, top panels).
However, the percentage of mature CD4
 
 
 
SP cells was sig-
nificantly higher (87 vs. 73%) in thymocytes derived from
 
E47
 
2
 
/
 
2
 
;AND mice, and the proportion of DP cells was
significantly lower (10 vs. 22%; Fig. 3, top panels). Impor-
tantly, we observed a similar trend in the peripheral T cell
populations. The ratio of CD4
 
1
 
 to CD8
 
1
 
 splenic T cells
increased from 
 
z
 
22 in the wild-type or heterozygous mice
expressing the AND TCR to 55 in the E47
 
2
 
/
 
2
 
;AND mice
(Fig. 3, middle panels). In the lymph nodes, the ratio of
CD4
 
1
 
 to CD8
 
1
 
 cells increased from 11 in the E47
 
1
 
/
 
1
 
;
AND mice to 69 in the E47
 
2
 
/
 
2
 
;AND mice (Fig. 3, bottom
panels). The increase in total percentage of T cells in the E47-
deficient lymph nodes (98 vs. 55%) is due to the complete
absence of B cells in the E2A- and E47-deficient mice (4,
15). Thus, there is a selective increase in only those SP cells
expressing the relevant TCR, and this increase is reflected
in the periphery. These data suggest that the absence of
E47 can markedly enhance the positive selection of class
II–restricted TCRs.
To determine whether the absence of E47 also promotes
increased selection of class I–restricted TCRs, we analyzed
E47-deficient mice expressing the H-Y TCR transgene,
which specifies reactivity with the male H-Y antigen pre-
sented by the H-2D
 
b
 
 class I molecule (27, 28). Expression
of the H-Y TCR transgene in females of the H-2
 
b
 
 back-
ground leads to positive selection of CD8 SP thymocytes
(27, 28). In contrast, thymocytes in male mice expressing
the H-Y TCR are deleted at the DP stage. Negative selec-
tion mediated by the H-Y TCR transgene was unaffected
by the absence of E47 (data not shown). However, E472/2;
H-Y female mice displayed an increased percentage of ma-
ture CD8 SP thymocytes compared with the E47 heterozy-
gous littermates (56.6 vs. 33.6%; Fig. 4 A). This phenotype
was accompanied by a significant decrease in the proportion
of immature DP thymocytes (29.6 vs. 46%; Fig. 4 A). Be-
Figure 2. E47 deficiency leads to altered thymocyte maturation. Two-
color flow cytometric analysis of TCR-a/b and CD69 expression on
thymocytes from a 5-wk-old E2A-deficient mouse and a heterozygous
littermate. The numbers in each quadrant indicate the percentage of thy-
mocytes in that population.
Figure 3. Absence of E2A leads to an increased generation
of mature SP cells in class II–restricted TCR transgenic mice.
Flow cytometric analysis of 4–6-wk-old E47-deficient mice
and littermate controls expressing the class II–restricted AND
TCR transgene. Thymocytes (top panels), splenocytes (middle
panels), and lymph node cells (bottom panels) were analyzed
by staining with anti-CD4–PE and anti-CD8a–FITC. The
numbers in each quadrant indicate the percentage of cells in
that population. Genotypes of the mice are indicated above
the thymic profiles. The numbers shown above the splenocyte
and lymph node panels indicate the CD4/CD8 ratio within
those populations.1609 Bain et al.
cause of continued rearrangement of endogenous a chain
genes in TCR transgenic mice, a fraction of the thymo-
cytes will express a TCR composed of the transgenic b
chain and an endogenous a chain (25, 27, 29). To analyze
the proportion of cells expressing the transgenic TCR-a/b,
we stained total thymocytes with the T3.70 antibody, which
reacts specifically with the transgenic a chain molecule
(30). Thymocytes isolated from E472/2;H-Y mice contained
Figure 4. Altered maturation of thymocytes in class I–restricted
TCR transgenic mice expressing decreased levels of E47. Flow cyto-
metric analysis of 4–6-wk-old E47-deficient female mice and litter-
mate controls expressing the class I–restricted H-Y TCR transgene.
(A) Thymocytes from E47 knockout and heterozygous littermate fe-
males were stained with anti-CD4–PE and anti-CD8a–FITC or with
the anti-Va3 antibody, T3.70, which recognizes the transgenic a
chain. The numbers in each quadrant indicate the percentage of cells
in that population, and the percentage of cells staining brightly for the
transgenic a chain is indicated in the histograms. (B) Splenocytes (top
panels) and lymph node cells (bottom panels) from female H-Y trans-
genics of the indicated E47 genotype were analyzed by staining with
anti-CD4–PE and anti-CD8a–FITC. The numbers in each quadrant
indicate the percentage of cells in that population. (C) Thymocytes
from an E47 heterozygous and knockout littermate expressing the
H-Y TCR transgene were analyzed by three-color flow cytometric
analysis for expression of CD4, CD8, and either TCR-a/b or CD69.
The boxed regions in the CD4 versus CD8 plots indicate the analysis
gates used to define the DP population. In the histogram plots, the
thin lines indicate staining on the E47 heterozygous H-Y DP cells,
and the thick lines indicate staining on the E47-deficient H-Y DP
cells. The third color antibody used in each case is indicated. (D) Thy-
mocytes (top panels), splenocytes (middle panels), and lymph node
cells (bottom panels) from female H-Y transgenics that are wild-type
or heterozygous for E47 were analyzed by staining with antibodies to
CD4 and CD8. The numbers in each quadrant indicate the percent-
age of cells in that population.1610 E2A Activity Regulates Thymocyte Selection
almost twice the percentage of cells expressing high levels
of both the transgenic a and b chains, consistent with a
higher proportion of mature CD8 SP T cells (Fig. 4 A).
The increased percentage of mature CD81 T cells ob-
served in the E472/2;H-Y mice is also reflected in the pe-
riphery. The ratio of CD81 to CD41 T cells is increased
from z0.4 in the E471/2;H-Y spleen to 1.2 in the E472/2;
H-Y spleen (Fig. 4 B, top panels). A similar change in the
CD8/CD4 ratio was observed in the lymph nodes (Fig. 4 B).
Therefore, like the E472/2;AND mice, the E472/2;H-Y
mice display an increase in only the percentage of cells ex-
pressing the relevant TCR, and the relative proportions of
CD4 and CD8 lineage cells are altered in the peripheral lym-
phoid organs as well. These changes in peripheral CD8/CD4
ratios from E47-deficient/TCR transgenic mice would not
be expected if the increase in proportion of thymic SP cells
was entirely the result of increased death within the DP
thymocyte population. In addition, a selective increase in
only the population of cells expressing the relevant TCR is
not consistent with a defect in emigration of mature SP
thymocytes from the thymus.
Interestingly, in addition to the increase in CD8 SP cells,
E472/2;H-Y thymi contained elevated percentages of DP
cells that expressed CD69 and high levels of TCR-a/b
(Fig. 4 C). Thus, a higher proportion of the DP population
is undergoing positive selection in the absence of E47.
Taken together, these data suggest that the absence of E47
results in increased selection to both class I– and class II–
restricted T cell receptors.
As described above, heterozygosity at the E47 locus does
not perturb maturation of SP thymocytes expressing class
II–restricted TCR transgenes. In contrast, we consistently
observed increases in the proportion of CD81 cells in fe-
male H-Y transgenic mice that were heterozygous for E47
compared with wild-type littermates (Fig. 4 D). In most
cases, the percentage of CD81 cells was increased in the
periphery of E471/2;H-Y mice as well (Fig. 4 D). Thus,
maturation of CD8 SP cells in mice expressing the H-Y
TCR transgene is influenced by the dosage of E47.
Absence of E2A Leads to the Appearance of DP Cells in Pe-
ripheral Lymphoid Organs of H-Y Transgenic Mice. In addition
to the increased production of CD8 SP cells, female E472/2;
H-Y mice displayed an aberrant population of T cells in
the peripheral lymphoid organs that expressed high levels
of CD8 and intermediate to high levels of CD4 (Fig. 4 A
and Fig. 5 A). To examine whether the peripheral DP
(PDP) population expressed markers characteristic of ma-
ture T lineage cells, we analyzed this population for the ex-
pression of TCR-a/b and HSA. The PDP cells expressed
HSA at a level similar to normal SP thymocytes, and signif-
icantly lower than the level of expression on thymic DP
cells (Fig. 5 B). However, the expression of HSA on the PDP
population is significantly higher than the level observed on
normal SP peripheral T cells (Fig. 5 B, right). TCR-a/b
expression on the PDP cells was identical to that of the ma-
ture SP T cells, with all of the cells expressing uniformly
high levels of TCR (Fig. 5 C). Taken together, the data
suggest that the PDP cells in the E472/2;H-Y mice are
positively selected T lineage cells that fail to complete mat-
uration before exiting to the periphery.
Absence of E47 Allows Inefficient Maturation of CD8 T Lineage
Development in the Absence of Class I MHC. As described
above, the absence of E47 promotes the development of SP
thymocytes. To determine whether the absence of E47 al-
lows the development of SP cells in the absence of an ap-
propriate signal, we bred the E47-deficient mice to b2M–
deficient mice, which virtually lack MHC class I expression
and produce very few mature CD8 SP thymocytes (31, 32).
Although the E47 deficiency did not promote CD8 lineage
development in the b2M-deficient background to wild-type
levels, we consistently noted a small percentage of TCRhi
CD8 SP cells in the E472/2;b2M2/2 thymi that were ab-
sent in the E471/2;b2M2/2 thymi (Fig. 6 A, and data not
shown). Furthermore, E472/2;b2M2/2 mice displayed a
higher proportion of TCRhi CD8 SP cells in the peripheral
lymphoid organs compared with the control littermates
(Fig. 6 B, and data not shown). The decreased CD4/CD8
Figure 5. Appearance of DP cells in the periphery of E47-deficient/
H-Y transgenic mice. 6-wk-old H-Y transgenic mice of the indicated
E47 genotype were analyzed by three-color flow cytometry for the ex-
pression of CD4, CD8, and either HSA (B) or TCR-a/b (C). The CD4
versus CD8 profiles for the thymocytes (top panels) and splenocytes (bot-
tom panels) are shown (A), and the numbers in each quadrant indicate the
percentage of cells in that population. The boxed regions in the CD4 ver-
sus CD8 plots (a–e) indicate the analysis gates used to define the popula-
tions analyzed in B and C. In the histogram plots (B and C), the lettered
arrows indicate the staining pattern for the corresponding boxed popula-
tions in A. To make comparisons clearer, the histograms were plotted in
pairs to compare the peripheral DP population with the thymic DP pop-
ulation (left panels) and with the SP populations (right panels).1611 Bain et al.
ratio from 146 in the E471/2;b2M2/2 spleen to 37 in the
E472/2;b2M2/2 spleen indicates that the absence of E47
allows for an increase in maturation of CD81 cells even in
the absence of the appropriate TCR–MHC interaction. Thus,
the data suggest that the downregulation of E2A activity
can promote thymocyte maturation.
Absence of E47 Leads to an Increased Production Rate of
Mature SP Thymocytes. The steady state size of the thymic
subpopulations is determined by the rate at which cells are
generated, the rate at which they die, and the rate at which
they emigrate from the thymus. To more directly assess the
effect of an E47 deficiency on the production of mature SP
T cells, we measured the kinetics of appearance of mature
thymocytes using the thymidine analogue BrdU. We ex-
posed E47-deficient mice and their heterozygous littermates
to BrdU in their drinking water and then analyzed for the
presence of BrdU and the expression of TCR-a/b and CD69
(Fig. 7, A and B). Because cells expressing medium to high
levels of TCR are not dividing, there is a lag in the appear-
ance of BrdU in these populations. As described above,
both the E47-deficient and control mice display this lag in
labeling of mature thymocytes, demonstrating that the ab-
sence of E47 does not lead to the aberrant proliferation of
the SP cells. Because the TCRmed-hi populations are nondi-
viding, the rate of appearance of BrdU in these populations
reflects the rate at which these cells are produced. In mice
deficient for E47, the rate of appearance of BrdU-labeled
TCRhiCD692 mature thymocytes is significantly enhanced,
suggesting that the relative proportion of cells that develop
into mature CD692 T cells is increased in the absence of
E47 (Fig. 7 B). In contrast, E47-deficient mice display a de-
crease in the rate of appearance of BrdU in the TCRmed
CD691 population (Fig. 7 B). Taken together, these data
suggest that the rate at which DP thymocytes mature into
TCRhiCD692 SP T cells is enhanced in the absence of E47.
Inhibition of E47 Binding Activity Promotes T Cell Differen-
tiation. As shown in Table I, E2A-deficient DP thymo-
cytes show reduced survival in vitro. However, the data
described above suggest that the absence of E47 also pro-
motes thymocyte positive selection. To test directly whether
lowering the activity of E47 promotes maturation, we used
a retroviral transduction system to study the effects of in-
hibiting E2A activity in an immature DP T cell line. The
mouse cDNA for Id3, a negative regulator of E2A binding
activity, was cloned into the retroviral vector S-003 (14).
This vector allows translation of both Id3 and enhanced
green fluorescent protein (EGFP) from one retroviral tran-
script. Thus, retroviral transductants can be identified by
the expression of EGFP. The S-003/Id3 and S-003 empty
vector constructs were transfected into the fNX-eco retro-
viral packaging line, and supernatants from these cells were
used to transduce virus into the T cells. The 16610D9 T
Figure 6. Development of CD81 cells in the E47-deficient mice requires MHC class I expression. E47-deficient mice were bred onto the b2M-defi-
cient background, and 4–6-wk-old littermates were analyzed for CD4, CD8, and TCR expression. Thymocytes (A) and splenocytes (B) from E47-defi-
cient and heterozygous littermates on a b2M-deficient or heterozygous background were analyzed by staining with anti-CD8a and anti-CD4. The num-
bers in each quadrant indicate the percentage of thymocytes in that population. The CD4/CD8 ratios for the spleens are indicated under the FACS®
plots in B.1612 E2A Activity Regulates Thymocyte Selection
cell line used was derived from a thymoma that developed
spontaneously in a p53-deficient mouse and was adapted to
culture. This T cell line expresses characteristics typical of
DP thymocytes, including high levels of HSA, intermedi-
ate levels of TCR, and low levels of CD5 and CD44 (Fig.
8 C). In addition, the 16610D9 cells express significant lev-
els of E2A binding activity (Fig. 8 A).
Id3 was transduced into the 16610D9 line and analyzed
48 h after infection for the expression of HSA, CD69, CD44,
CD5, TCR b chain, and CD4 and CD8. The early stages of
positive selection are marked by increased expression of
CD69, CD5, and TCR (20, 22, 24, 25). During the later
stages of positive selection, CD44 is upregulated whereas
HSA is downregulated (33). In addition, T cells undergoing
the initial stages of positive selection downmodulate both
CD4 and CD8 expression (34). At the time of analysis, z85%
of both the control and Id3-infected cells were EGFP1 (Fig.
8 B). The ability of Id3 to inhibit E47 binding activity was
assayed by electrophoretic mobility shift assay using an E-box
probe. E47 and HEB binding activity was easily detectable
in the control transduced cells, but dropped to 10–20% of
that level in the Id3 transductants (Fig. 8 A). Thus, overex-
pression of Id3 is sufficient to inhibit E47 binding activity
within the 16610D9 cells.
The infected cells were then analyzed by flow cytometry
for the expression of the indicated markers. Strikingly, the
Id3 transductants displayed altered expression of all the
markers analyzed. In particular, expression of both TCR-b
and CD5 increased dramatically in the cells lacking E47
binding activity, but was unchanged in the nontransduced
cells (Fig. 8 C). In addition, the Id3 transductants clearly
upregulated CD69 and CD44 expression, as evidenced by
an increase in both the mean linear value of the histogram
and the median linear value of the histograms (Fig. 8 C).
On the other hand, HSA expression was marginally down-
regulated in the Id3-expressing cells (Fig. 8 C). Further-
more, we detected a dramatic downmodulation of CD4
and CD8 coreceptor expression in Id3-transduced cells (Fig.
8 E). Thus, these data clearly show that Id3-transduced T
cells acquire phenotypic characteristics of thymocytes un-
dergoing positive selection. Taken together, these data
demonstrate that lowering the level of E47 activity pro-
motes T cell differentiation in vitro and are consistent with
a key role for E47 in promoting DP thymocyte maturation
in vivo.
Discussion
Immature thymocytes have the ability to undergo two
distinct fates. A DP thymocyte can be selected to mature
into either a CD41 or CD81 T cell, or alternatively it may
undergo cell death. Although a large number of signaling
molecules have been implicated in thymic selection, their
nuclear targets have remained largely unknown. Here, we
show that the activity of one particular transcriptional regu-
lator, E47, is important in regulating thymocyte positive se-
lection. Our data indicate that the relative level of E47 can
influence thymocyte selection to both the CD4 and CD8
lineages. In the absence of E47 activity, the rate of produc-
tion of TCRhiCD692 thymocytes is enhanced, resulting in
increased percentages of SP thymocytes. In a TCR trans-
genic background, a deficiency in E47 results in an increase
in positive selection of only those T cells expressing the rel-
evant TCR. In addition, inhibition of E47 activity within a
DP T cell line induces the cells to differentiate. Based on
these observations, we propose that the downregulation of
E2A activity promotes thymocyte maturation.
A Role for E47 in Controlling Thymocyte Maturation.
Mice deficient for E2A display an increased percentage of
mature SP thymocytes coupled with a decreased propor-
tion of DP cells. Here we show that the E2A-deficient mice
exhibit increases in DP cell death in vitro. Although it is
likely that a decreased rate of DP survival could contribute
to the observed phenotype, it is doubtful that the increase
in proportion of SP cells is solely a result of increased death
within the DP population. Our kinetic data demonstrate
that the absence of E2A activity additionally promotes thy-
mocyte maturation. Furthermore, E47-deficient TCR trans-
genic mice display a corresponding increase of SP T cells
expressing only the relevant TCR in both the thymus and
Figure 7. Increased rate of appearance of mature thymocytes in mice
deficient for E47. Mice were continuously exposed to the thymidine ana-
logue BrdU in their drinking water for the indicated times and then ana-
lyzed for BrdU content and TCR-a/b and CD69 surface expression. (A)
Representative TCR-a/b/CD69 FACS® plots for E47-deficient and
heterozygous mice. (B) Rate of appearance of BrdU-labeled TCRmed
CD691 cells (left) and TCRhiCD692 cells (right). The percent BrdU-
labeled cells of total cells is plotted against the time of continuous expo-
sure to BrdU. The gates used to define the TCRmedCD691 cells and
TCRhiCD692 cells are shown in A as R1 and R2, respectively. The
numbers plotted are the averages from two mice.1613 Bain et al.
the peripheral lymphoid organs. The appearance of DP T
cells expressing characteristics of positively selected cells in
the periphery of E472/2;H-Y mice also indicates that the
absence of E2A affects DP thymocyte maturation. More-
over, our data show that CD81 T cells have the ability to
mature in the absence of class I, albeit with low efficiency,
when E47 is lacking. Finally, inhibition of E47 activity
within a DP T cell line alters the expression of markers that
correlate with DP maturation. Taken together, these data
demonstrate that a downregulation of E47 activity pro-
motes thymocyte maturation and that a combination of in-
creased DP cell death and enhanced maturation contributes
significantly to the phenotype observed in the E47-defi-
cient mice.
This raises the question of how E47 is involved in posi-
tive selection. TCR–MHC interactions that induce positive
selection must have two important effects. These signals
must rescue the cells from apoptosis and promote matura-
tion. Recent data indicate that the restoration of E47 activ-
ity in E2A-deficient DP thymoma cell lines leads to pro-
grammed cell death (18). It is possible that the continued
presence of E2A activity in DP thymocytes that have re-
ceived a signal through the TCR contributes to the induc-
tion of apoptosis. Thus, only those cells that downregulate
E2A activity survive. We note that the thymic phenotype
of E47-deficient mice shows similarities to the bcl-2 trans-
genic mice, including a higher percentage of CD8 SP cells
and an alteration in the CD4/CD8 ratio (7, 35–38). Like
bcl-2 expression, decreased E47 activity might prolong the
survival of the DP thymocytes, thus leading to enhanced
production of CD81 cells. However, as mentioned above,
DP thymocytes lacking E2A show an increase in cell death
in vitro, whereas bcl-2 expression prolongs DP thymocyte
survival (36, 38). Additionally, expression of bcl-2 pro-
motes CD81 thymocyte maturation in MHC class I–defi-
cient mice and in class II–restricted TCR transgenic mice,
whereas the absence of E47 does not (35; Figs. 3 and 6). Fi-
nally, in contrast to the E47-deficient mice, the excess CD81
thymocytes that develop in the bcl-2 transgenic mice do not
survive in the periphery (35, 36).
Recently, activation of the Notch signaling pathway has
been shown to upregulate several markers that correlate with
Figure 8. Inhibition of E47 activity in a DP T cell line promotes
differentiation. The 16610D9 DP T cell line was retrovirally infected
with Id3 or control (S-003) virus. 48 h after infection, the cells were
harvested and WCE was prepared as described from half of the cells
while the remainder of the cells was stained with the indicated anti-
bodies and analyzed by flow cytometry. (A) E2A binding activity was
analyzed by electrophoretic mobility shift assay using a labeled mE5
oligo probe. Lanes 1–4, S-003–infected cells; lanes 5–8, Id3-infected
cells. Extracts were preincubated with mAbs (Ab) against E47 (lanes 2
and 6), E12/HEB (lanes 3 and 7), or E12 (lanes 4 and 8) before the
addition of the probe. The arrow at left indicates the E47-containing
complex. (B) EGFP expression on the S-003 (top) and Id3 (bottom)
infected cells. The gates used to define the GFP1 and GFP2 popula-
tions are indicated in the histograms. (C) Infected cells were stained
with the indicated antibodies and analyzed by flow cytometry. The
left panels show staining patterns on the GFP1 cells, and the right panels show staining patterns on the GFP2 cells within the same infection. Thin line
indicates staining on the S-003–infected cells, and thick line indicates staining on the Id3-infected cells. (D) CD4/CD8 staining on GFP1 (top panels) and
GFP2 (bottom panels) from control (S-003) and Id3-infected cells. The percentage of CD4/CD8 DP cells (boxed area) is indicated in each plot.1614 E2A Activity Regulates Thymocyte Selection
DP maturation. In particular, a constitutively active frag-
ment of Notch was capable of upregulating bcl-2 expres-
sion in DP thymomas and rendering these cells resistant to
glucocorticoid-induced apoptosis (39). Interestingly, like
the E47-deficient mice, activated Notch1 transgenics have
increased percentages of CD81 thymocytes (40). However,
a significant population of CD81 thymocytes can develop
in Notch1 transgenic mice lacking expression of class I MHC,
whereas only a small CD81 population can develop in class
I–deficient mice lacking E47 (40). Nonetheless, it is pos-
sible that Notch signaling regulates E2A activity. In fact, oth-
ers have shown that activated Notch1 and Notch2 effec-
tively inhibit E47 activity in transient transfection assays (41).
It is conceivable that the lack of E47 activity lowers the
threshold of avidity required for positive selection. This
model has been proposed to explain the phenotype of the
activated Notch1 transgenic mice (39). For example, the
absence of E47 might allow for the development of T cells
that would normally die by neglect because of an insuffi-
cient affinity for MHC. It is thought that CD8 lineage
commitment requires weaker signals from the TCR com-
pared with the strength of the signal required for CD4 lin-
eage commitment (42, 43). If less stringent signals are re-
quired for commitment to the CD8 lineage, then a slight
lowering of the threshold affinity of positive selection may
result in an even greater increase in CD81 cells compared
with CD41 cells. Such a model might explain the decrease
in the CD41/CD81 thymocyte ratio in E2A-deficient mice
and the finding that more CD81 T cells develop in MHC
class I–deficient mice that also lack E47 expression. Thus,
the absence of E47 might allow for the development of some
T cells that would normally die by neglect.
E47 Target Genes. The data described above suggest that
E47 activity is downregulated during the final stages of thy-
mocyte maturation. A key step during the transition of a DP
to SP thymocyte is the termination of TCR-a rearrange-
ments. Previous studies have suggested a link between E2A
activity and RAG expression, which is also downregulated in
immature thymocytes upon interaction of the TCR with the
appropriate MHC–peptide complex (44). For example, ex-
pression of both RAG-1 and RAG-2 can be activated in a
pre-T cell line by the ectopic expression of E47 (9). Addi-
tionally, E2A and HEB have been implicated in regulating
RAG transcription in committed T lineage cells (11). Consis-
tent with this idea, E2A-deficient thymocytes show decreased
levels of both RAG-1 and RAG-2 transcripts (Bain, G., un-
published observations). However, RAG levels are not com-
pletely abolished, and TCR V(D)J recombination proceeds in
E2A-deficient mice, presumably due to the presence of an
HEB homodimeric complex detectable in E2A-deficient thy-
mocyte extracts (7). We would like to suggest that an interac-
tion of a TCR with the appropriate peptide–MHC complex
results in the downregulation of total HLH activity, which
leads to the abatement of RAG expression (44). We also note
that lowering the DNA binding activity of E47 in a DP cell
line leads to the activation of CD5, CD69, and TCR expres-
sion and the downmodulation of CD4, CD8, and HSA lev-
els. Thus, our observations indicate that E47 directly or indi-
rectly regulates the expression of a wide variety of genes that
are characteristic of thymocyte maturation.
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